risk ratio for coronary heart disease mortality in 59 randomized controlled trials of...
TRANSCRIPT
Risk Ratio for Coronary Heart Disease Mortality in 59 Randomized Risk Ratio for Coronary Heart Disease Mortality in 59 Randomized Controlled Trials of Cholesterol-Lowering InterventionsControlled Trials of Cholesterol-Lowering Interventions
StatinsStatins 0.69 (0.59-0.80)0.69 (0.59-0.80)n=13 (16,228/11,279)n=13 (16,228/11,279)n-3 fatty acidsn-3 fatty acids 0.44 (0.18-1.07)0.44 (0.18-1.07)n=3 (1,348/1,349)n=3 (1,348/1,349)FibratesFibrates 0.98 (0.78-1.24)0.98 (0.78-1.24)n=12 (9,873/11,496)n=12 (9,873/11,496)ResinsResins 0.71 (0.51-0.99)0.71 (0.51-0.99)n=8 (3,280/3,257n=8 (3,280/3,257HormonesHormones 1.04 (0.93-1.17)1.04 (0.93-1.17)n=8 (4,516/9,039)n=8 (4,516/9,039)Niacin acidsNiacin acids 0.85 (0.83-1.10)0.85 (0.83-1.10)n=2 (1,196/2,932)n=2 (1,196/2,932)DietDiet 0.91 (0.82-1.01)0.91 (0.82-1.01)n=16 (48,481/59,042)n=16 (48,481/59,042)
1.01.0.9.9.8.8.7.7.6.6.5.5.4.4.3.3.2.2.1.1 22
Risk Ratio % 95% CIRisk Ratio % 95% CIBenefitBenefit HarmHarm
Arterioscler Thromb Vasc Biol. 1999;19:187-195Arterioscler Thromb Vasc Biol. 1999;19:187-195
Risk Ratio for Overall Mortality in 59 Randomized Controlled Risk Ratio for Overall Mortality in 59 Randomized Controlled Trials of Cholesterol-Lowering InterventionsTrials of Cholesterol-Lowering Interventions
StatinsStatins 0.79 (0.71-0.89)0.79 (0.71-0.89)n=13 (16,228/11,279)n=13 (16,228/11,279)n-3 fatty acidsn-3 fatty acids 0.66 (0.53-0.88)0.66 (0.53-0.88)n=3 (1,348/1,349)n=3 (1,348/1,349)FibratesFibrates 1.06 (0.78-1.48)1.06 (0.78-1.48)n=12 (9,873/11,496)n=12 (9,873/11,496)ResinsResins 0.85 (0.66-1.08)0.85 (0.66-1.08)n=8 (3,280/3,257n=8 (3,280/3,257HormonesHormones 1.09 (1.00-1.20)1.09 (1.00-1.20)n=8 (4,516/9,039)n=8 (4,516/9,039)Niacin acidsNiacin acids 0.96 (0.86-1.08)0.96 (0.86-1.08)n=2 (1,196/2,932)n=2 (1,196/2,932)DietDiet 0.97 (0.81-1.15)0.97 (0.81-1.15)n=16 (48,441/59,042)n=16 (48,441/59,042)
1.01.0.9.9.8.8.7.7.6.6.5.5.4.4 22
Risk Ratio % 95% CIRisk Ratio % 95% CIBenefitBenefit HarmHarm
Arterioscler Thromb Vasc Biol. 1999;19:187-195Arterioscler Thromb Vasc Biol. 1999;19:187-195
Risk Ratio for Mortality Other Than From CHD in 59 Randomized Risk Ratio for Mortality Other Than From CHD in 59 Randomized Controlled Trials of Cholesterol-Lowering InterventionsControlled Trials of Cholesterol-Lowering Interventions
StatinsStatins 0.97 (0.81-1.16)0.97 (0.81-1.16)n=13 (16,228/11,279)n=13 (16,228/11,279)n-3 fatty acidsn-3 fatty acids 1.16 (0.63-2.12)1.16 (0.63-2.12)n=3 (1,348/1,349)n=3 (1,348/1,349)FibratesFibrates 1.16 (0.63-2.12)1.16 (0.63-2.12)n=12 (9,873/11,496)n=12 (9,873/11,496)ResinsResins 1.07 (0.74-1.55)1.07 (0.74-1.55)n=8 (3,280/3,257n=8 (3,280/3,257HormonesHormones 1.29 (1.08-1.57)1.29 (1.08-1.57)n=8 (4,516/9,039)n=8 (4,516/9,039)Niacin acidsNiacin acids 0.99 (0.76-1.29)0.99 (0.76-1.29)n=2 (1,196/2,932)n=2 (1,196/2,932)DietDiet 1.00 (0.95-1.05)1.00 (0.95-1.05)n=16 (48,481/59,042)n=16 (48,481/59,042)
1.01.0.9.9.8.8.7.7.6.6 22
Risk Ratio % 95% CIRisk Ratio % 95% CIBenefitBenefit HarmHarm
Arterioscler Thromb Vasc Biol. 1999;19:187-195Arterioscler Thromb Vasc Biol. 1999;19:187-19533